DE3521679A1 - Verfahren zum binden von igg an protein a - Google Patents

Verfahren zum binden von igg an protein a

Info

Publication number
DE3521679A1
DE3521679A1 DE19853521679 DE3521679A DE3521679A1 DE 3521679 A1 DE3521679 A1 DE 3521679A1 DE 19853521679 DE19853521679 DE 19853521679 DE 3521679 A DE3521679 A DE 3521679A DE 3521679 A1 DE3521679 A1 DE 3521679A1
Authority
DE
Germany
Prior art keywords
protein
immunoglobulin
molecules
solution
buffer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19853521679
Other languages
German (de)
English (en)
Other versions
DE3521679C2 (enExample
Inventor
Hector Larkspur Calif. Juarez-Salinas
Gary Steven Livermore Calif. Ott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Rad Laboratories Inc
Original Assignee
Bio Rad Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24499435&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3521679(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bio Rad Laboratories Inc filed Critical Bio Rad Laboratories Inc
Publication of DE3521679A1 publication Critical patent/DE3521679A1/de
Application granted granted Critical
Publication of DE3521679C2 publication Critical patent/DE3521679C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/828—Protein A
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE19853521679 1984-06-22 1985-06-18 Verfahren zum binden von igg an protein a Granted DE3521679A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/623,797 US4704366A (en) 1984-06-22 1984-06-22 Process for binding IgG to protein A

Publications (2)

Publication Number Publication Date
DE3521679A1 true DE3521679A1 (de) 1986-01-02
DE3521679C2 DE3521679C2 (enExample) 1989-08-24

Family

ID=24499435

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19853521679 Granted DE3521679A1 (de) 1984-06-22 1985-06-18 Verfahren zum binden von igg an protein a

Country Status (4)

Country Link
US (1) US4704366A (enExample)
JP (2) JPS6112631A (enExample)
DE (1) DE3521679A1 (enExample)
GB (1) GB2160530B (enExample)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283323A (en) * 1985-08-07 1994-02-01 The United States Of America As Represented By The Department Of Health And Human Services Method of producing immune response
US4977247A (en) * 1986-02-14 1990-12-11 Genex Corporation Immobilized protein G variants and the use thereof
SE459662B (sv) * 1986-03-21 1989-07-24 Pharmacia Ab Hybrid-dna-molekyl som kodar foer ett protein med samma igg specificitet som protein g, plasmid innehaallande densamma samt foerfarande foer framstaellning av proteinet
US5089605A (en) * 1987-03-13 1992-02-18 Repligen Corporation Immobilized immunoglobulin-binding proteins
JPS6419024A (en) * 1987-07-15 1989-01-23 Tosoh Corp Separation of immunoglobulin g subclass
US4981961A (en) * 1988-09-12 1991-01-01 Bioprobe International, Inc. Synthetic affinity ligand compositions and methods for purification and recovery of organic molecules
US4933435A (en) * 1989-04-05 1990-06-12 Bioprobe International Antibody purification process
US5151504A (en) * 1989-11-17 1992-09-29 E. R. Squibb & Sons, Inc. Method for purification of monoclonal antibodies
US5077391A (en) * 1989-12-01 1991-12-31 Raison Robert L Purification of immunoglobulin M
JPH03185000A (ja) * 1989-12-15 1991-08-12 Tosoh Corp プロテインＡと免疫グロブリンＧ（ＩｇＧ）との結合方法
US5200471A (en) * 1990-11-05 1993-04-06 Minnesota Mining And Manufacturing Company Biomolecules covalently immobilized with a high bound specific biological activity and method of preparing same
US5245016A (en) * 1991-01-31 1993-09-14 University Of Utah Research Foundation Pseudomonas maltophilia immunoglobulin binding protein and methods for its use
WO1994022918A1 (en) * 1993-03-29 1994-10-13 Minnesota Mining And Manufacturing Company Method of coupling ligands within porous supports (p.e. azlactone) and uses thereof
US5593822A (en) * 1993-12-07 1997-01-14 John Wayne Cancer Institute IgG depleted serum preparations and methods for antibody production
US5561045A (en) * 1994-01-04 1996-10-01 Intracel Corporation Detection reagent, article, and immunoassay method
EP0701566A1 (en) * 1994-04-01 1996-03-20 Unisyn Technologies, Inc. High salt binding buffer for immunoglobulin purification with a synthetic affinity ligand
MXPA05005558A (es) * 2002-11-26 2005-07-26 Protein Design Labs Inc Anticuerpos quimericos y humanizados para integrina ( 5 ( 1 que modulan la angiogenesis.
US7276589B2 (en) * 2002-11-26 2007-10-02 Pdl Biopharma, Inc. Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis
US7285268B2 (en) * 2002-11-26 2007-10-23 Pdl Biopharma, Inc. Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis
ATE531388T1 (de) * 2004-03-24 2011-11-15 Abbott Biotherapeutics Corp Verwendung von anti-alpha5beta1-antikörpern zur hemmung der krebszellproliferation
AU2008282331A1 (en) * 2007-07-27 2009-02-05 Facet Biotech Corporation Pharmaceutical combinations comprising a tyrosine kinase inhibitor and an antibody against integrin alpha 1 beta 5 (CD49E)
US20100158893A1 (en) * 2008-12-19 2010-06-24 Baxter International Inc. Systems and methods for obtaining immunoglobulin from blood
WO2011064910A1 (ja) * 2009-11-25 2011-06-03 パナソニック株式会社 免疫測定方法
BR112012014937B1 (pt) 2009-12-18 2021-01-19 Novartis Ag método de produção de um anticorpo, fragmento de anticorpo ou proteína de fusão fc purificada usando uma matriz de cromatografia de afinidade
WO2012149197A2 (en) 2011-04-27 2012-11-01 Abbott Laboratories Methods for controlling the galactosylation profile of recombinantly-expressed proteins
US9034656B2 (en) 2011-11-21 2015-05-19 Abaxis, Inc. Signal amplification in lateral flow and related immunoassays
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
TW201348247A (zh) * 2012-05-21 2013-12-01 Abbvie Inc 利用蛋白質ａ親和性層析之非人類抗體之新穎純化
US9249182B2 (en) 2012-05-24 2016-02-02 Abbvie, Inc. Purification of antibodies using hydrophobic interaction chromatography
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
HK1211981A1 (en) 2012-09-02 2016-06-03 Abbvie Inc. Methods to control protein heterogeneity
SG11201507230PA (en) 2013-03-12 2015-10-29 Abbvie Inc Human antibodies that bind human tnf-alpha and methods of preparing the same
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014159579A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
TWI691716B (zh) 2014-08-13 2020-04-21 美商艾巴希斯公司 電漿特異性結合搭配物檢定中之信號放大
US11566082B2 (en) 2014-11-17 2023-01-31 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
DK3331818T3 (da) 2015-08-04 2024-08-12 Zoetis Services Llc Signalforstærkning i opløsningsbaserede plasmoniske assays med specifkke bindingspartnere
JP7031934B2 (ja) 2016-05-11 2022-03-08 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 分離マトリックス
JP7122974B2 (ja) 2016-05-11 2022-08-22 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 変異免疫グロブリン結合ポリペプチド
EP3455241B1 (en) 2016-05-11 2022-02-23 Cytiva BioProcess R&D AB Method of cleaning and/or sanitizing a separation matrix
WO2017194592A1 (en) 2016-05-11 2017-11-16 Ge Healthcare Bioprocess R&D Ab Method of storing a separation matrix
US10654887B2 (en) 2016-05-11 2020-05-19 Ge Healthcare Bio-Process R&D Ab Separation matrix
US10730908B2 (en) 2016-05-11 2020-08-04 Ge Healthcare Bioprocess R&D Ab Separation method
US10703774B2 (en) 2016-09-30 2020-07-07 Ge Healthcare Bioprocess R&D Ab Separation method
US12448411B2 (en) 2016-09-30 2025-10-21 Cytiva Bioprocess R&D Ab Separation method
MX2019008970A (es) 2017-01-30 2019-12-19 Abay Sa Ensayos de socio de unión específico de plasmón basados en solución y nanoestructuras metálicas.
US11155575B2 (en) 2018-03-21 2021-10-26 Waters Technologies Corporation Non-antibody high-affinity-based sample preparation, sorbent, devices and methods

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3960720A (en) * 1973-03-23 1976-06-01 Exploaterings Aktiebolaget T.B.F. Gel product for separation purposes and method of using the product for hydrophobic salting out adsorption

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4430318A (en) * 1978-11-29 1984-02-07 The United States Of America As Represented By The Department Of Health And Human Services Immunoassay utilizing 125 I Protein A
US4230685A (en) * 1979-02-28 1980-10-28 Northwestern University Method of magnetic separation of cells and the like, and microspheres for use therein
AU570911B2 (en) * 1981-11-06 1988-03-31 Baylor College Of Medicine Immunoadsorbent based on immobilized protein a and its use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3960720A (en) * 1973-03-23 1976-06-01 Exploaterings Aktiebolaget T.B.F. Gel product for separation purposes and method of using the product for hydrophobic salting out adsorption

Non-Patent Citations (18)

* Cited by examiner, † Cited by third party
Title
"Affinity Chromatography der Firma Parmacia Fine Chemicals (1979), S. 7, 16, 92 u. 93
"Hybridoma Techniques", EMBO, SKMB Course 1980, Basel, S. 36 und 37
"Protein Purification" von R.K. Scopes, Springer-Verlag New York(1982), S. 43-48 u. 139-140
2 Chromatogr. Synth. Biol. Polym.,S.337-340(1978) *
Biochemistry 20, S. 2361(1980) *
Biochemistry, Vol. 20, No. 9, 28. April 1981, S. 2361-2370
Druckschrift IBF "Practical Guide for Use in *
Druckschrift IBF "Practical Guide for Use in Affinity Chromatograph and related techniques" 65-66, 138(1983)
Experimental Immunochemistry, 2. Aufl., S. 628-629, Charles C. Thomas, Hrsg.,(1961)
GODING, J.: "Monoclonal Antibodies: Principles and Practice"(1983), Academic Press, S. 197-198 *
HOPPE_SEYLER`S, Z.: Physiol. Chem. 359. S. 975, 984(1978) *
Immunological Communications ll, S. 189-200(1982 *
J. Imm- Meth. 64, S. 1-6(1983) *
LINDMARK, R.: Dissertation "Studies on Protein A from Staphylococcus Aureus", Uppsala 1981, Veröffentlichungen zur Dissertation: J.Immunol. Meth., 62, S. 1-13(1983) *
Produktinformation der Firma Pharmacia Fine Chemicals überOctyl-Sepharose CL-4B, Phenyl-Sepharose CL-4B aus dem Jahre 1979, S. 1-13
SANDBERG, H. (Hrsg.): Proceedings of the International Workshop on Technology for Protein Separationand Improvement of Blood Plasma Fractionation, DHEW Publication No. (NIH) 78-1422(1978), S. 431 *
Scand. J. Immunol. 9(1979), S. 359-364
Svensk Farmaceutisk Tidskrift, 86(10), S. 18-22(1982) *

Also Published As

Publication number Publication date
US4704366A (en) 1987-11-03
GB2160530B (en) 1987-10-28
DE3521679C2 (enExample) 1989-08-24
GB2160530A (en) 1985-12-24
JPH0543719B2 (enExample) 1993-07-02
GB8515261D0 (en) 1985-07-17
JPH0455440B2 (enExample) 1992-09-03
JPH04234899A (ja) 1992-08-24
JPS6112631A (ja) 1986-01-21

Similar Documents

Publication Publication Date Title
DE3521679C2 (enExample)
DE2322533C2 (de) Verfahren zum Binden von Immunoglobulin und Hilfsmittel zur Durchführung des Verfahrens
DE2319495C2 (de) Verfahren zum selektiven, reversiblen Binden von Biomolekülen an ein Adsorbens in einer chromatographischen Säule
DE2720704C2 (de) Neues Glycoprotein, Verfahren zu seiner Herstellung und seine Verwendung
DE2322552C2 (de) Verfahren zum Abtrennen von Protein A aus Staphylococcus aureus aus einer Flüssigkeit
DE3486453T2 (de) Monoklonale Antikörper gegen neue Faktor-VIII Gerinnungspolypeptide
DE3544400A1 (de) Verfahren zum abtrennen von bovinem lactoferrin von kuhmilch und reinigen desselben
DE19538625C2 (de) Verfahren zur Abtrennung von Albumin aus Serum durch Membranionenaustauschchromatographie
DE68904732T2 (de) Ionenaustausch und trennungsmethode.
DE2640387C3 (de) Gewebespezifisches Protein und Verfahren zu dessen Herstellung
DE2720655A1 (de) Verfahren zur isolierung von albumin
EP0014756A1 (de) Plazentaspezifisches Gewebsprotein PP10 und Verfahren zu seiner Anreicherung
DE2616984C3 (de) Verfahren zur Isolierung und Reinigung eines plazentenspezifischen Glycoproteins
DE69200460T2 (de) Agglutinationskomplex zum Nachweis von Blutgruppen.
EP0001812A1 (de) Verfahren zur Herstellung gereinigten Alpha-1-Fetoproteins und dessen Verwendung
DE3809796A1 (de) Verfahren zum reinigen eines 168 kd-proteins von mycoplasma pneumoniae
DE19729591A1 (de) Mittel zur Behandlung und/oder Prophylaxe von Mikrozirkulationsstörungen
CH639394A5 (de) Verfahren zur herstellung von immunglobulinpraeparationen mit verminderter komplementaktivitaet.
DE2718325C2 (de) Leucinreiches 3,1-S-α↓2↓-Glykoprotein sowie dessen Verwendung
DE3779914T2 (de) Neue lectine, abgeleitet von bakteriellen haaren.
DE102010054767B4 (de) Verfahren zur Trennung, Aufkonzentration und/oder Reinigung von (Blut)Plasmaprotein, Viren oder Virenbestandteilen
DE69223929T2 (de) Verfahren zur Bindung des Immunoglobulin G an Protein A
DE3524585C2 (enExample)
DE2611723C3 (de) Verfahren zur Herstellung von einheitlichen kugelförmigen HBsAg-Teilchen
DE2828235B1 (de) Verfahren und Adsorptionsmittel zur Isolierung und Reindarstellung von Enzymen aus einer Roh-Enzym-Loesung

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8363 Opposition against the patent
8331 Complete revocation